Literature DB >> 19018765

De novo 16p13.11 microdeletion identified by high-resolution array CGH in a fetus with increased nuchal translucency.

L W Law1, T K Lau, T Y Fung, T Y Leung, C C Wang, K W Choy.   

Abstract

OBJECTIVE: We investigated the application of high-resolution microarray-based comparative genomic hybridisation (array CGH) on a fetus showing increased nuchal translucency (NT).
DESIGN: Case study.
SETTING: Tertiary referral obstetrics unit. SAMPLE: Pregnant woman attended the antenatal clinic.
METHODS: Conventional karyotyping and genetic test was carried out for the alpha-globin gene. High-resolution array CGH using the high-density 244K Agilent microarray was performed on fetal blood sample by cordocentesis to investigate the possibility of any genomic imbalance. MAIN OUTCOME MEASURES: Detection of chromosomal abnormality.
RESULTS: Karyotyping analysis showed 46,XY. Molecular genetic diagnosis confirms the fetus has Hb-H constant spring disease but cannot explain the increased NT to 3.2 mm. Array CGH analysis discovered a 1.32-Mb microdeletion on chromosome 16p13.11. Deletion at 16p13.11 has been implicated to predispose to autism and/or mental retardation. Baby was delivered at 40 weeks of gestation, and follow up was carried out at 3 months of age without sign of mental retardation/developmental delay.
CONCLUSIONS: This case study demonstrated that array CGH can accurately calibrate the size and identify de novo interstitial chromosome imbalances. However, the presence of chromosome copy variants with unknown clinical significance currently limits its wider scale application in prenatal diagnosis and needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018765     DOI: 10.1111/j.1471-0528.2008.01948.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  Clinical utility gene card for: 16p13.11 microdeletion syndrome.

Authors:  Maria Tropeano; Joris Andrieux; David A Collier
Journal:  Eur J Hum Genet       Date:  2013-10-09       Impact factor: 4.246

2.  Array study in fetuses with nuchal translucency above the 95th percentile: a 4-year observational single-centre study.

Authors:  Edgar Coello-Cahuao; María Ángeles Sánchez-Durán; Inés Calero; María Teresa Higueras; Mayte Avilés García; Carlota Rodó; Nerea Maiz; Alberto Plaja Rustein; Neus Castells-Sarret; Carmen Mediano-Vizuete; Elena Carreras
Journal:  Arch Gynecol Obstet       Date:  2022-04-29       Impact factor: 2.344

Review 3.  Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era.

Authors:  Yong-Hui Jiang; Yi Wang; Xu Xiu; Kwong Wai Choy; Amber Nolen Pursley; Sau W Cheung
Journal:  Crit Rev Clin Lab Sci       Date:  2014-05-30       Impact factor: 6.250

4.  Whole Exome Sequencing in 16p13.11 Microdeletion Patients Reveals New Variants Through Deductive and Systems Medicine Approaches.

Authors:  Paola Granata; Dario Cocciadiferro; Alessandra Zito; Chiara Pessina; Alessandro Bassani; Fabio Zambonin; Antonio Novelli; Mauro Fasano; Rosario Casalone
Journal:  Front Genet       Date:  2022-03-15       Impact factor: 4.599

5.  [Single nucleotide polymorphism microarray in prenatal diagnosis of fetuses with absent nasal bone].

Authors:  Jialing Yu; Yixi Sun; Junjie Hu; Yeqing Qian; Yuqin Luo; Minyue Dong
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.